Supporting its potential on-target mechanism of action, Compound 10 treatment increased acetylation of the HDAC6 substrate α-tubulin in treated MM cell lines, while effects on acetylated histone H4 was significantly less pronounced. This evidence concerns the gene HDAC6 and Miyoshi myopathy.